ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: April 12, 2011
Last updated: October 6, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: October 27, 2014